MedTrace Logo

HDL Function Dietary Supplement Safety and QOL

NCT04097119 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-04-06

No results posted yet for this study

Summary

Nutritional supplements are routinely purchased by consumers with suboptimal HDL to support their health, lifestyle and overall quality of life. Many such products receive minimal evaluation prior to marketing. This study aims to evaluate a specific nutritional supplement for its safety, tolerance and acceptability as well as the potential for positive impact on quality of life.

Conditions

  • HDL
  • Health, Subjective

Interventions

DIETARY_SUPPLEMENT

Dietary supplementation

Subjects receive a specific dietary supplementation designed to support HDL function daily for 12 weeks

Sponsors & Collaborators

  • Hypertension Institute, Nashville

    collaborator OTHER

  • Metagenics, Inc.

    lead INDUSTRY

Principal Investigators

  • Mark Houston, MD · Hypertension Institute

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-18
Primary Completion
2020-08-30
Completion
2022-12-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04097119 on ClinicalTrials.gov